Mark L Peterson

Title: Mark L Peterson: Innovator in Antiviral Synthesis

Introduction

Mark L Peterson is a notable inventor based in Maryland Heights, MO (US). He has made significant contributions to the field of antiviral agents through his innovative processes and inventions. With a total of 2 patents, Peterson has focused on the synthesis of purine substituted compounds that have important applications in medicine.

Latest Patents

Peterson's latest patents include groundbreaking work on carbonate intermediates for the synthesis of purine substituted compounds. One of his notable inventions relates to a new process for preparing the 1R-cis isomer of carbovir, which is an antiviral agent. This invention involves intermediates of the formula (Vlb), where X can be chloro, bromo, or iodo, and R represents a (C1-6) alkyl group. Another significant patent focuses on the synthesis of purine substituted cyclopentene derivatives, which also includes the preparation of optically active compounds and novel intermediates used in the process.

Career Highlights

Throughout his career, Mark L Peterson has worked with reputable organizations such as Glaxo Inc. and the University of Minnesota. His work in these institutions has allowed him to develop and refine his innovative processes, contributing to advancements in antiviral research.

Collaborations

Peterson has collaborated with esteemed colleagues, including Robert Vince and John W Lackey. These partnerships have fostered a collaborative environment that has enhanced the development of his inventions.

Conclusion

Mark L Peterson's contributions to the field of antiviral synthesis through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important medical compounds.